0.71 0.01(1.46%)07/03/2024
Seres Therapeutics Inc (MCRB)
Seres Therapeutics Inc (MCRB)
Showing latest 10 records. To view more news, Upgrade to PRO plan with only $1
| Headline | Time (ET) | Source |
|---|---|---|
| Seres Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | 06/07 16:00 | globenewswire.com |
| Nestlé Health Science agrees to acquire global rights to VOWST®, product it launched in June 2023 | 06/06 07:00 | prnewswire.com |
| Seres Therapeutics Enters Into Memorandum of Understanding For Vowst™ Asset Sale to Nestlé Health Science | 06/06 06:30 | globenewswire.com |
| Seres Therapeutics, Inc. (MCRB) Q1 2024 Earnings Call Transcript | 05/11 17:34 | seekingalpha.com |
| Seres Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates | 05/08 07:00 | businesswire.com |
| Seres Therapeutics to Announce First Quarter 2024 Financial Results and Business Update on May 8, 2024 | 05/06 09:30 | businesswire.com |
| Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT | 04/09 07:00 | businesswire.com |